Long Term Care Journal
Tuesday, May 15, 2018
FDA approves first epoetin alfa biosimilar for the treatment of anemia - FDA Press Releases
FDA approves Retacrit (epoetin alfa-epbx) as a biosimilar to Epogen/Procrit (epoetin alfa) for the treatment of anemia
from Food and Drug Administration--Press Releases https://ift.tt/2wFn9S8
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment